Discover 243 paid clinical trials in Lebanon, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Lebanon has about 15,000 residents and hosts the only National Cancer Institute designated comprehensive cancer centre in New Hampshire. Cancer research leads, including lung, ovarian, melanoma, and sarcoma studies, much of it run through the National Cancer Institute and cooperative groups, with epilepsy and inflammatory bowel disease the most visible non cancer areas.
Filter
2
Filter results
Results: 243
Active & Responsive
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Lebanon NH, Burlington MA, Boston MA, Farmington CT,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase 2, Phase 3, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Lebanon NH, Boston MA, Torrington CT, Waterbury CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase 3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Lebanon NH, Saint Johnsbury VT, Springfield MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase 2, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Lebanon NH, Saint Johnsbury VT, Boston MA, Verona NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase 3, Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Location: Lebanon NH, Worcester MA, Portland ME, Boston MA,
Sponsor: Chris Goss
Sex: All
Age: 6+
Code: NCT05548283
Recruiting
Active & Responsive
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
for
Cesarean Delivery, General Anesthesia
Location: Lebanon NH, Albany NY, Boston MA, New Haven CT,
Sponsor: Yale University
Sex: Female
Age: 15 - 55
Code: NCT06030063
Recruiting
Active & Responsive
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
for
Mesial Temporal Lobe Epilepsy
Location: Lebanon NH, Boston MA, Hackensack NJ, New Brunswick NJ,
Sponsor: UniQure Biopharma B.V.
Sex: All
Age: 18 - 70+
Code: NCT06063850
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Lebanon NH, Boston MA, Syracuse NY, Great Neck NY,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase 3, Recruiting
Active & Responsive
Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas
for
Fistula in Ano
Location: Lebanon NH, Pittsburgh PA
Sponsor: ECM Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07035925
Recruiting
Active & Responsive
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigoâ„¢ Aspiration System (STRIDE II)
for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Lebanon NH, Worcester MA, New Haven CT, New York NY,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT06747117
Recruiting
Active & Responsive
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
for
Carcinoma, Non-Small-Cell Lung
Location: Lebanon NH, Philadelphia PA, Columbus OH, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04165798
Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Lebanon NH, New York NY, Hackensack NJ, Mineola NY,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase 1, Phase 2, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Montpelier VT, Concord NH, Albany NY, Boston MA,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer